Autoimmune markers in vitiligo patients appear correlated with obsession and phobia

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 7, 2012, Pages 861-867

  Moretti, S ^a   Arunachalam, M ^a   Colucci, R ^a   Pallanti, S ^a   Kline, J A ^b   Berti, S ^a   Lotti, F ^a   Lotti, T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOIMMUNE MARKER; BIOLOGICAL MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; OUTPATIENT CARE; PHOBIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; QUESTIONNAIRE; SCHOOL CHILD; SCREENING; STRESS; VITILIGO; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; PHOBIC DISORDERS; QUESTIONNAIRES; VITILIGO; YOUNG ADULT;

EID: 84862773742     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04171.x     Document Type: Article

References (25)

1. Schallreuter KU, Lemke R, Brandt O, et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 1994; 188: 269-275. (Pubitemid 24105481)
2. Daneshpazhooh M, Mostofizadeh M, Behjati J, et al. Anti-thyroid peroxidase antibody and vitiligo. A controlled study. BMC Dermatol 2006; 6: 3.
3. Urpe M, Pallanti S, Lotti T,. Psychosomatic factors in dermatology. Dermatol Clin 2005; 23: 601-608. (Pubitemid 41169832)
4. O'Leary A,. Stress, emotion and human immune function. Psychol Bull 1990; 108: 363-382.
5. Pallanti S, Lotti T, Urpe M,. Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the evolutionary hypothesis. Dermatol Clin 2005; 23: 695-701. (Pubitemid 41174573)
6. Kostopoulou P, Jouary T, Quintard B, et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol 2009; 161: 128-133.
7. Linthorst Homan MW, Spuls PI, de Korte J, et al. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol 2009; 61: 411-420.
8. Kent G, Al'Abadie M,. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996; 35: 895-898. (Pubitemid 26422112)
9. Matoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: Prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002; 16: 573-578. (Pubitemid 35385745)
10. Matoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol 2001; 28: 424-432. (Pubitemid 32862058)
11. Pulimood S, Rajagopalan B, Rajagopalan M, et al. Psychiatric morbidity among dermatology inpatients. Nat Med J India 1996; 9: 208-210. (Pubitemid 126459612)
12. Taieb A, Picardo on Behalf of VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European task force. Pigment Cell Res 2007; 20: 27-35. (Pubitemid 46090162)
13. Crown S, Crisp AH,. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966; 112: 917-923.
14. Dioguardi N, Comazzi AM, Nielsen NP,. Psychological profile of the spa user. Preliminary study of motivations for spa treatment. Minerva Med 1984; 75: 2793-2798. (Pubitemid 15155460)
15. Weiss MG, Doongaji DR, Siddhartha S, et al. The Explanatory Model Interview Catalogue (EMIC). Contribution to cross-cultural research methods from a study of leprosy and mental health. Br J Psychiatry 1992; 160: 819-830.
16. Stojanovich L, Zandman-Goddard G, Pavlovich S, et al. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007; 6: 421-426. (Pubitemid 46824096)
17. Barbosa F, Mota C, Alves M, et al. Alexithymia in systemic lupus erythematosus patients. Ann NY Acad Sci 2009; 1173: 227-234.
18. Carta MG, Hardoy MC, Carpiniello B, et al. A case control study on psychiatric disorders in Hashimoto disease and euthyroid goitre: not only depressive but also anxiety disorders are associated with thyroid autoimmunity. Clin Pract Epidemiol Ment Health 2005; 1: 23.
19. Carta MG, Loviselli A, Hardoy MC, et al. The link between thyroid autogimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. MC Psychiatry 2004; 4: 25.
20. Carta MG, Hardoy MC, Boi MF, et al. Association between panic disorder, major depressive disorder and celiac disease: a possible role of thyroid autoimmunity. Psychosom Res 2002; 53: 789-793.
21. Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
22. Stojanovich L, Marisavljevich D,. Stress as a trigger of autoimmune disease. Autoimmun Rev 2008; 7: 209-213.
23. Manolache L, Benea V,. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 921-928. (Pubitemid 47103722)
24. Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom 2003; 72: 150-158. (Pubitemid 36469864)
25. Sampogna F, Raskovic D, Guerra L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol 2008; 159: 351-359. (Pubitemid 352009864)